SinglePoint Inc. (OTC:SING) Eliminates Debt and Gains Additional $1m in Funding

SinglePoint, Inc. (OTC: SING) has raised more than $300,000 and has signed a Letter of Intent to secure additional funding of $1 million.

Today's update follows news of the Company's recent Letter of Intent to acquire a stake in Convectium, which created the world's first machine capable of filling cartridges or disposables en mass for wholesale distribution to cannabis dispensaries.

Alliance Growth Corp. (CSE:AGC) Assembles Top-Teir Growing Team

Alliance Growth Corp. executives announce that the Company has executed the founders agreement with a private Health Canada Licensed Producer Applicant based in Ontario, Canada.

The next step is a $25,000 first payment for the equity investment. The agreement will include long term plantlet supply contract and an off-take agreement at wholesale cost for flower to be used for CBD oil extraction at the Cannabis Botany Centre.

GW Pharma Looks Better Than Ever to Investors

The world’s largest company involved with producing therapeutics derived from cannabis posted a fiscal first-quarter loss of $19.25 million.

GW Pharmaceuticals (NASDAQ:GWPH) said it lost $0.768 per American depository share (ADS) in its fiscal first quarter, well below analysts’ consensus estimate of $1.20. Each ADS represents 12 ordinary shares.

Invictus MD (CSE:IMH, OTC:IVITF) Acquires 150 acres to Increase Production

Invictus MD Strategies Corp. (CSE:IMH, OTC:IVITF) is pleased to announce that on February 6, 2017 it has acquired 100% of the outstanding shares from its current shareholders.

They have acquired 60,000 square feet of secured perimeter for its current production facility located on 150 acres. They have already submitted plans for additional buildings on the Property including a 30,000 square foot facility.

Aphria Receives Conditional Approval to Graduate to the TSX

Tags APH , APHQF , Aphria , Leamington , Ontario , OTCQB , Press Release , Shareholders , TSX , TSX VENTURE , Vic Neufeld LEAMINGTON, Ontario, Feb. 6, 2017 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH) (OTCQB:APHQF) is pleased to announce it has received conditional approval from the Toronto Stock Exchange (the “TSX”) to graduate from the TSX Venture Exchange and list its common shares on the TSX.

QuikFlo Moves into the US Marijuana Space with Letter of Intent to Acquire Licensed Nevada Production Facility in Addition to a CBD Infused Product Company.

By: Filing Services Canada via Filing Services Canada February 06, 2017 at 17:20 PM EST QuikFlo Moves into the US Marijuana Space with Letter of Intent to Acquire Licensed Nevada Production Facility in Addition to a CBD Infused Product Company. QuikFlo Moves into the US Marijuana Space with Letter of Intent to Acquire Licensed Nevada Production Facility in Addition to a CBD Infused Product Company.

Aphria (TSXV:APH) Graduates to the TSX

Aphria (TSXV:APH, OTC:APHQF) is pleased to announce it has received conditional approval from the Toronto Stock Exchange to graduate from the TSX Venture Exchange and list its common shares on the TSX.

QuikFlo (TSXV:QF) Moves into the US Marketplace

QuikFlo Moves into the US Marijuana Space with Letter of Intent to Acquire Licensed Nevada Production Facility in Addition to a CBD Infused Product Company.

The acquisitions include a 12,000 sq. ft. licensed medical marijuana cultivation/production facility and packaging center with over $1 million in medicinal sales in its first year of operation.  The second acquisition is of a start-up company that develops and markets hemp based and CBD infused products for sales nationwide. 

"Marapharm" Announces That its Subsidiary has Developed its Product Line for Oils and Edibles in Nevada

"Marapharm" Announces That its Subsidiary has Developed its Product Line for Oils and Edibles in Nevada KELOWNA, British Columbia , February Marapharm Ventures Inc., (OTCQB: MRPHF) is the sole owner of Econevada LLC, which is the holder of a provisional production license for lab tested oils and edible cannabis infused products which will be produced in Marapharm's facility. The facility is presently under construction in Apex Industrial Park, Las Vegas, Nevada .

$VNNYF $VIN.CN News - Vinergy Resources/MJ BioPharma to Acquire Majority Stake in Multinational Plant Breeder with CAD $14,000,000 in Annual Sales

Financial News Media Featured News Published - February 2, 2017 $VNNYF $VIN.CN News - Vinergy Resources/MJ BioPharma to Acquire Majority Stake in Multinational Plant Breeder with CAD $14,000,000 in Annual Sales - (FinancialNewsMedia.com Wire) VANCOUVER, BRITISH COLUMBIA - ( http://www.financialnewsmedia.com News Alert) - Vinergy Resources Ltd. (OTCQB:VNNYF) (CSE:VIN)("Vinergy" or the "Company") (CSE:VIN.CN) in conjunction with its proposed acquisition of MJ Biopharma (announced December 14, 2016) is pleased to announce that it has signed a Letter of Intent (LOI) to acquire up to 51% of a European multinational plant breeding company ("Target"). The Target ...

Canopy Growth Corp. Changes It's Stock Symbol to WEED (TSX:WEED)

Canopy Growth Corp. formerly (CSE:CGC) has officially changed its stock market ticker to WEED (TSX:WEED).

The company helped "ring the bell" to open trading on the Toronto Stock Exchange this morning as it began trading under the new symbol.

You can now hold a little WEED in your portfolio.

Tetra Bio-Pharma Inc. Receives Notice of Authorization from Health Canada for the Conduct of its Clinical Trial with its PPTGR topical product $TBP.ca

Received a Notice of Authorization from the Therapeutic Products Directorate, Health Canada, for its planned clinical trial for PhytoPain Topical Gel Relief Being developed as a locally administered therapeutic for the treatment of Chemotherapy-Induced Neuropathic Pain OTTAWA, ONTARIO-(Feb. 1, 2017) - PhytoPain Pharma Inc. (“PPP”), a subsidiary of Tetra Bio-Pharma (“ Tetra ” or the “ Company “) (CSE:TBP), a pharmaceutical company focused on developing and commercializing therapeutic cannabis-based products for the treatment of pain and other medical conditions announces that it has received a Notice of Authorization from the Therapeutic Products Directorate, Health Canada, for its planned clinical trial for PhytoPain Topical ...